PitchCentric
Celina Dubin
Updated 12 days ago · Refreshed hourly
science

Celina Dubin

Hosted by Celina Dubin MD · 🇺🇸 US · EN · 28 episodes

Where this show ranks

Episodes
28
Last ep.
12 days ago
Avg length
9m
Booking Probability™
38
Stretch.
Sign in to score against your profile.
Estimated audience
,
Audience size not yet estimated
Listen Score
20
Niche reach.
Virality (30d)
49
Steady cadence.

Pitch Analysis

Sign in to see how your Guest Score compares to this show's Required Pod Score and get a Stretch / Match-fit / Anchor verdict.
Required Pod Score
80/ 100
Premium

Established thought leaders with verified media credentials.

Guest openness
Not signalled recently
Best topics to pitch
science

About this podcast

Celina Dubin recently graduated from medical school with a distinction in research in May 2022. She is currently a resident physician in New York City, where she is training to become a dermatologist.

science

About the host

Celina Dubin MD hosts Celina Dubin, a science show with 28 episodes published.

Recent episodes

Our AI reads these to draft pitches

Celina Dubin MD-Using random forest models to predict drug reaction with eosinophilia and systemic symptoms development from CBC parameters

May 28, 20262m0

This article was co-authored by Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of Investigative Dermatology. Read the original abstract here: htt

Show notes

Celina Dubin MD et al- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study

May 18, 20261m0

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this case series study, which was published in the Journal of the American Academy of Dermatology Case Rep

Show notes

Celina Dubin MD Shares - Vitiligo and Associated Comorbidities. A Case–Control Study in the US All of Us Database

May 13, 20261m0

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this case-control study, published in Clinical and Experimental Dermatology. LEARN MORE ABOUT T

Show notes

Celina Dubin MD - A Phase 2a Trial of Brepocitinib for Cicatricial Alopecia

May 10, 20262m0

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this phase 2a trial, which appeared in the Journal of the American Academy of Dermatology. VIEW FULL DETAI

Show notes

Celina Dubin MD- Vitiligo May Be Associated With an Increased Genetic Risk of Cardiovascular Disease

May 3, 20262m0

This research letter was co-authored by Dr. Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of the American Academy of Dermatology International.

Show notes

Dr. Celina Dubin, MD-Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients

Apr 16, 20262m0

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, which was published in the Journal of Allergy and Clinical Immunology. The study ex

Show notes

Dr Celina Dubin-Cross-sectional study of blood biomarkers - moderate/severe alopecia areata patients

Apr 16, 20262m0

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this study, which appeared in the Journal of the American Academy of Dermatology. The goal of the study wa

Show notes

Celina Dubin MD- Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals

Apr 16, 20262m0

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, published in the Journal of Investigative Dermatology (JID). The study evaluated di

Show notes

Andres D. Parga, Celina Dubin, Donald Rudikoff Drug-Induced Phototoxicity in Vitiligo The Role of Hydrochlorothiazide in Photosensitivity Dermatitis

Dec 30, 20250m0

Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis. Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-

Show notes

Celina Dubin, MD- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study

Dec 14, 20251m0

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this study, which was published in the Journal of the American Academy of Dermatology (JAAD). Read the ful

Show notes

Celina Dubin & Angela Lamb. Hair Regrowth In Endocrine Therapy Alopecia With Dutasteride Treatment.

Aug 22, 20232m0

Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer. Celina Dubin MD & Angela Lamb MD Read the full version here: https://www.ncbi.nlm.nih.gov/pmc/articles

Show notes

Celina Dubin MD -An Integrated Scalp + Blood Biomarker Approach

Dec 17, 20222m0

Celina Dubin together with; Jacob W. Glickman, Dante Dahabreh, Joseph Han, Ester Del Duca, Yeriel D. Estrada, Ning Zhang, Grace W. Kimmel, Giselle Singer, James G. Krueger, Ana B. Pavel, & Emma Guttman-Yassky present a u

Show notes

Celina Dubin MD - Oral Janus KinaseSYK Inhibition Suppresses Inflammation And Improves

Dec 14, 20222m0

ASN002 is an oral inhibitor of the Janus kinase/spleen tyrosine kinase signaling pathways, targeting several cytokine axes (T2/T22/T17/T1) and epidermal differentiation. Originally appeared as a medical research paper: w

Show notes

Celina Dubin MD -Scalp And + Profiling Of Frontal Fibrosing Alopecia

Dec 12, 20221m0

To characterize FFA compared to normal and alopecia areata, using broad molecular profiling, and to identify biomarkers linked to disease severity. Originally published in PubMed: pubmed.ncbi.nlm.nih.gov/34044102/

Show notes

Celina Dubin MD shares Stand SAFE 2022

Oct 18, 20221h 42m0

Stand SAFE 2022- "Gun Violence Prevention Initiatives" https://www.standsafe.org/the-team

Show notes

Celina Dubin - How Swede It Is, Summer In Fiskebäckskil

Sep 22, 20223m0

"One of my earliest memories of Fiskebäckskil is being six years old, spending days sitting on the side of the road making a little store, like a lemonade stand. " Celina Dubin recalls family vacations in Fiskebäckskil

Show notes

Celina Dubin MD- Member SAFE Board Of Directors, Mission Statement.

Sep 20, 20221m0

Firearms are a real "Health Threat" and require the research, education and policy-makin to keep us all healthy. https://www.standsafe.org/the-team

Show notes

Celina Dubin MD - Objective Evaluation Of Skin Sensitivity Across Fitzpatrick Skin Types

Sep 15, 20221m0

Skin sensitivity may be best defined as self-reported intolerance to application of skincare products. It is commonly believed that individuals with darker skin are generally less sensitive, while those lighter skin are

Show notes

Celina Dubin -Chicago Sun Times Gun Violence Op - Ed

Aug 23, 20222m0

Co-founders Celina Dubin & Deniz Cataltepe's letter to the editor on the topic of: Hippocratic Oath and firearm violence prevention. Having recently qualified as an MD, May 2022 this topic is even more pressing. Original

Show notes

Celina Dubin - Virtual Speaker Series.

Apr 28, 202249m0

The East Harlem School At Exodus House Virtual Speaker Series featured Celina Dubin. Available on Youtube: https://www.youtube.com/watch?v=K5WBjeV3qXw

Show notes

Sponsors and advertisers

Sponsor detection runs nightly. Check back soon.

Audience demographics

Age
25-54
Consumer type
Lifelong learners

Topics covered

science

Successful pitch examples

No public pitch examples yet for this show.

Generate your own personalised pitch

Best industries to pitch Celina Dubin for

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.

Similar podcasts to Celina Dubin

Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

Frequently asked questions

How do I pitch Celina Dubin as a podcast guest?

To pitch Celina Dubin, visit http://www.linkedin.com/in/celina-dubin for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent science coverage.

Who is the host of Celina Dubin?

Celina Dubin is hosted by Celina Dubin MD. The show is categorised under science and has published 28 episodes.

How many episodes does Celina Dubin have?

Celina Dubin has published 28 episodes.

What topics does Celina Dubin cover?

Celina Dubin regularly covers science. It sits in the science category.

Is it hard to get booked on Celina Dubin?

Celina Dubin is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.

Is Celina Dubin currently accepting guest pitches?

Celina Dubin hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.

How long are Celina Dubin episodes?

Episodes of Celina Dubin average 9 minutes. a focused format where a clear narrative arc and tight preparation matter most.

What guest credentials does Celina Dubin typically look for?

Our data rates Celina Dubin's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.

Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 12 days ago.

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.